212
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Unilateral Acute Iris Transillumination Syndrome following Uneventful Phacoemulsification Surgery with Intracameral Moxifloxacin

, MD, FEBOORCID Icon & , MD
Pages 1984-1987 | Received 08 Feb 2021, Accepted 06 Apr 2021, Published online: 18 May 2021

References

  • Tugal-Tutkun I, Araz B, Taskapili M, et al. Bilateral acute depigmentation of the iris: report of 26 new cases and four-year follow-up of two patients. Ophthalmology. 2009;116(8):1552–1557.e1. doi:10.1016/j.ophtha.2009.02.019.
  • Tugal-Tutkun I, Onal S, Garip A, et al. Bilateral acute iris transillumination. Arch Ophthalmol. 2011;129(10):1312–1319. doi:10.1001/archophthalmol.2011.310.
  • Gonul S, Bozkurt B. Bilateral acute depigmentation of the iris (BADI): first reported case in Brazil. Arq Bras Oftalmol. 2014;77(3):201–202. doi:10.5935/0004-2749.20140051.
  • Kawali A, Mahendradas P, Shetty R. Acute depigmentation of the iris: a retrospective analysis of 22 cases. Can J Ophthalmol. 2019;54(1):33–39. doi:10.1016/j.jcjo.2018.03.020.
  • Gonul S, Bozkurt B, Okudan S, Tugal-Tutkun I. Bilateral acute iris transillumination following a fumigation therapy: a village-based traditional method for the treatment of ophthalmomyiasis. Cutan Ocul Toxicol. 2015;34(1):80–83. doi:10.3109/15569527.2014.886589.
  • Light JG, Falkenberry SM. Unilateral bilateral acute iris transillumination-like syndrome after intracameral moxifloxacin injection for intraoperative endophthalmitis prophylaxis. JCRS Online Case Rep. 2019;7(1):3–5. doi:10.1016/j.jcro.2018.08.001.10.
  • Peñaranda-Henao M, Reyes-Guanes J, Muñoz-Ortiz J, et al. Anterior uveitis due to intracameral moxifloxacin: a case report. Ocul Immunol Inflamm. 2020;1–4. Published online ahead of print, May 29, 2020. doi:10.1080/09273948.2020.1757120.
  • Sánchez-Sánchez C, Puerto B, López-Caballero C, Contreras I. Unilateral acute iris depigmentation and transillumination after glaucoma surgery with mitomycin application and intracameral moxifloxacin. Am J Ophthalmol Case Rep. 2020;27(18):100639. doi:10.1016/j.ajoc.2020.100639.
  • Zubicoa A, Echeverria-Palacios M, Mozo Cuadrado M, Compains Silva E. Unilateral acute iris transillumination-like syndrome following intracameral moxifloxacin injection. Ocul Immunol Inflamm. 2020;1–2. Published online ahead of print, September 25, 2020. doi:10.1080/09273948.2020.1817495.
  • Gonul S, Bakbak B. Anterior uveitis due to intracameral moxifloxacin: a case report. Ocul Immunol Inflamm. September 18, 2020:1–2. Epub ahead of print. PMID: 32946301. doi:10.1080/09273948.2020.1797118.
  • Fuller JJ, McGwin G. Phakic status affects vitreous penetration of topical moxifloxacin. Arch Ophthalmol. 2006;124(5):749. doi:10.1001/archopht.124.5.749-a.
  • Ucakhan OO, Akbel V, Biyikli Z, Kanpolat A. Comparison of corneal curvature and anterior chamber depth measurements using the manual keratometer, Lenstar LS 900 and the Pentacam. Middle East Afr J Ophthalmol. 2013;20(3):201–206. doi:10.4103/0974-9233.114791.
  • Mahanty S, Kawali AA, Dakappa SS. et al. Aqueous humor tyrosinase activity is indicative of iris melanocyte toxicity. Exp Eye Res. 2017;162:79–85. doi:10.1016/j.exer.2017.07.006.
  • Perin A, Lyzogubov V, Bora N, et al. In vitro assessment of moxifloxacin toxicity to human iris pigment epithelium. Invest Ophthalmol Vis Sci. 2015;56:5729.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.